Category: GI Dynamics
The ECRI Institute releases its watch list of 10 technologies hospital C-suite executives should look out for in 2015.
Automated robotic systems used to combat hospital-acquired infections topped the ECRI Institute’s "2015 Top 10 Hospital C-Suite Watch List," an annual report on technologies healthcare executives should look out for in the next year to 18 months.
There was a significant amount of turnover this year in the corner offices of medical device companies, including exits by some of medtech's biggest names.
There was a revolving door on medtech's corner office this year, with more than 35 CEOs leaving their positions through planned transitions, retirement or termination, according to a MassDevice.com analysis.
Wound care giant Acelity says it snared Smith & Nephew's orthopedic reconstruction president Guarav Agarwal, for its newly created president of business & innovation role.
GI Dynamics says it plans to lay off 10% of its workforce, including longtime CFO Robert Crane, as part of a restructuring plan that's still under development.
GI Dynamics said yesterday that it's planning to cut 10% of its workforce as it develops a restructuring plan.
The move includes the departure of longtime CFO Robert Crane effective immediately, according to a press release. Lexington, Mass.-based GI Dynamics reported 67 employees in its 2013 annual report.
Here's a look at some of the top regulatory stories for medical device companies this week: Neuromod wins CE Mark for tinnitus device; Vascular Solutions wins FDA nod for Gel-Block embolization foam; Philips wins FDA clearance for IQon Spectral CT system; EU allows GI Dynamics EndoBarrier back on the market; Diabetes: FDA approves Animas Vibe with DexCom's G4 Platinum CGM
GI Dynamics says it can restart sales of its EndoBarrier weight loss device in Europe, having resolved concerns over use guidelines and how it reports adverse events.
Here's a look at some of the top Wall Street stories for medical device companies this week: 5 factors affecting the future of medtech; Medtech VC deals post double-digit increases in Q3; Breast implant maker Sientra sets IPO range; GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare; GI Dynamics proposes 1-for-10 reverse stock split